DEXCOM INC (DXCM) Stock Analyst Ratings
NASDAQ:DXCM • US2521311074
73.26 USD
+0.18 (+0.25%)
At close: Feb 23, 2026
73.26 USD
0 (0%)
After Hours: 2/23/2026, 4:48:17 PM
ChartMill assigns a Buy % Consensus number of 84% to DXCM. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 87.74. This target is 19.76% above the current price.
- DXCM was analyzed by 37 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about DXCM.
- In the previous month the buy percentage consensus was at a similar level.
- DXCM was analyzed by 37 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-17 | Truist Securities | Reiterate | Buy -> Buy |
| 2026-02-13 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-02-13 | BTIG | Reiterate | Buy -> Buy |
| 2026-02-13 | Barclays | Maintains | Underweight -> Underweight |
| 2026-02-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-02-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2026-01-12 | Barclays | Downgrade | Equal-Weight -> Underweight |
| 2026-01-09 | Bernstein | Maintains | Outperform -> Outperform |
| 2025-12-17 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-12-11 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-02 | Morgan Stanley | Upgrade | Equal-Weight -> Overweight |
| 2025-11-25 | Evercore ISI Group | Initiate | In-Line |
| 2025-11-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-07 | Argus Research | Maintains | Buy -> Buy |
| 2025-11-03 | UBS | Maintains | Buy -> Buy |
| 2025-11-03 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-03 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-10-31 | TD Cowen | Maintains | Buy -> Buy |
| 2025-10-31 | BTIG | Maintains | Buy -> Buy |
| 2025-10-31 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-31 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-10-31 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-31 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-31 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-31 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-21 | Stifel | Reiterate | Buy |
| 2025-10-15 | Truist Securities | Maintains | Buy -> Buy |
| 2025-10-07 | Citigroup | Maintains | Buy -> Buy |
| 2025-10-01 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-09-29 | Canaccord Genuity | Maintains | Buy -> Buy |
DEXCOM INC / DXCM FAQ
What do analysts expect the price target to be for DEXCOM INC (DXCM)?
37 analysts have analysed DXCM and the average price target is 87.74 USD. This implies a price increase of 19.76% is expected in the next year compared to the current price of 73.26.
How do analysts rate DEXCOM INC (DXCM)?
The consensus rating for DEXCOM INC (DXCM) is 84.3243 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover DEXCOM INC (DXCM) stock?
The number of analysts covering DEXCOM INC (DXCM) is 37.